{"transactions":[{"id":1118242,"issuer":{"id":4785,"kind":"organization","name":"MoonLake Immunotherapeutics"},"owners":[{"id":78740,"kind":"person","name":"Sturge Simon","position":1,"cik":"0001920785","reported_name":"Sturge Simon","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Buy","published_at":"2025-06-09T09:08:48.000Z","date":"2025-06-05","kind":"grant","planned":false,"acquired":true,"shares":6682,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option represents a right to purchase a total of 6,682 Class A Ordinary Shares of the Issuer, which will vest in full the earlier of (i) June 5, 2026 and (ii) the date of the Issuer's next annual general meeting of shareholders, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":6682,"derivative":{"exercise_price":48.83,"expiration_date":"2035-06-05","underlying":"Class A ordinary shares, par value $0.0001 per share","underlying_shares":6682},"source":{"system":"sec-edgar","filing":"0001213900-25-052370","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1920785/000121390025052370/ownership.xml","form_type":"4"}},{"id":1389442,"issuer":{"id":4785,"kind":"organization","name":"MoonLake Immunotherapeutics"},"owners":[{"id":78740,"kind":"person","name":"Sturge Simon","position":1,"cik":"0001920785","reported_name":"Sturge Simon","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A ordinary shares, par value $0.0001 per share","published_at":"2024-10-08T16:01:32.000Z","date":"2024-10-04","kind":"sale","planned":false,"acquired":false,"shares":171000,"price":53.72,"value":9186120.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported represents the weighted average sale price per share. The shares were sold in multiple transactions at prices ranging from $53.00 to $55.34. Upon request by the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price."}],"balance_after":171980,"source":{"system":"sec-edgar","filing":"0001213900-24-086271","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1920785/000121390024086271/ownership.xml","form_type":"4"}},{"id":1487175,"issuer":{"id":4785,"kind":"organization","name":"MoonLake Immunotherapeutics"},"owners":[{"id":78740,"kind":"person","name":"Sturge Simon","position":1,"cik":"0001920785","reported_name":"Sturge Simon","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Buy","published_at":"2024-06-07T16:59:23.000Z","date":"2024-06-06","kind":"grant","planned":false,"acquired":true,"shares":7688,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option represents a right to purchase a total of 7,688 Class A Ordinary Shares of the Issuer, which will vest in full the earlier of (i) June 6, 2025, (ii) the date of the Issuer's next annual general meeting of shareholders and (iii) the date of a Change in Control (as defined in the MoonLake Immunotherapeutics 2022 Equity Incentive Plan) of the Issuer, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":7688,"derivative":{"exercise_price":42.44,"expiration_date":"2034-06-06","underlying":"Class A ordinary shares, par value $0.0001 per share","underlying_shares":7688},"source":{"system":"sec-edgar","filing":"0001213900-24-050826","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1920785/000121390024050826/ownership.xml","form_type":"4"}},{"id":1768015,"issuer":{"id":4785,"kind":"organization","name":"MoonLake Immunotherapeutics"},"owners":[{"id":78740,"kind":"person","name":"Sturge Simon","position":1,"cik":"0001920785","reported_name":"Sturge Simon","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common shares, par value CHF 0.10 per share, of MoonLake AG","published_at":"2023-10-03T19:34:12.000Z","date":"2023-10-01","kind":"exercise","planned":false,"acquired":false,"shares":10196,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The common shares of MoonLake AG may be exchanged at the holder's option into Class A ordinary shares at a rate of 1 common share of MoonLake AG for 33.638698 Class A ordinary shares, rounded to the nearest whole share. Upon any such exchange of a common share of MoonLake AG, the corresponding Class C ordinary share of the Issuer will be automatically cancelled."},{"field":"kind","element":"transactionCoding","label":"F1","text":"On October 1, 2023, the Reporting Person exchanged 10,196 common shares of MoonLake Immunotherapeutics AG (\"MoonLake AG\") for 342,980 Class A ordinary shares of the Issuer. In connection with the exchange, 342,980 Class C ordinary shares of the Issuer were automatically cancelled by the Issuer for no consideration."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The common shares of MoonLake AG may be exchanged at the holder's option into Class A ordinary shares at a rate of 1 common share of MoonLake AG for 33.638698 Class A ordinary shares, rounded to the nearest whole share. Upon any such exchange of a common share of MoonLake AG, the corresponding Class C ordinary share of the Issuer will be automatically cancelled."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The common shares of MoonLake AG may be exchanged at the holder's option into Class A ordinary shares at a rate of 1 common share of MoonLake AG for 33.638698 Class A ordinary shares, rounded to the nearest whole share. Upon any such exchange of a common share of MoonLake AG, the corresponding Class C ordinary share of the Issuer will be automatically cancelled."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The common shares of MoonLake AG may be exchanged at the holder's option into Class A ordinary shares at a rate of 1 common share of MoonLake AG for 33.638698 Class A ordinary shares, rounded to the nearest whole share. Upon any such exchange of a common share of MoonLake AG, the corresponding Class C ordinary share of the Issuer will be automatically cancelled."}],"balance_after":0,"derivative":{"underlying":"Class A ordinary shares, par value $0.0001 per share","underlying_shares":342980},"source":{"system":"sec-edgar","filing":"0001013762-23-001303","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1920785/000101376223001303/ownership.xml","form_type":"4"}},{"id":1768014,"issuer":{"id":4785,"kind":"organization","name":"MoonLake Immunotherapeutics"},"owners":[{"id":78740,"kind":"person","name":"Sturge Simon","position":1,"cik":"0001920785","reported_name":"Sturge Simon","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class C ordinary shares, par value $0.0001 per share","published_at":"2023-10-03T19:34:12.000Z","date":"2023-10-01","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":342980,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"The common shares of MoonLake AG may be exchanged at the holder's option into Class A ordinary shares at a rate of 1 common share of MoonLake AG for 33.638698 Class A ordinary shares, rounded to the nearest whole share. Upon any such exchange of a common share of MoonLake AG, the corresponding Class C ordinary share of the Issuer will be automatically cancelled."},{"field":"kind","element":"transactionCoding","label":"F1","text":"On October 1, 2023, the Reporting Person exchanged 10,196 common shares of MoonLake Immunotherapeutics AG (\"MoonLake AG\") for 342,980 Class A ordinary shares of the Issuer. In connection with the exchange, 342,980 Class C ordinary shares of the Issuer were automatically cancelled by the Issuer for no consideration."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The common shares of MoonLake AG may be exchanged at the holder's option into Class A ordinary shares at a rate of 1 common share of MoonLake AG for 33.638698 Class A ordinary shares, rounded to the nearest whole share. Upon any such exchange of a common share of MoonLake AG, the corresponding Class C ordinary share of the Issuer will be automatically cancelled."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001013762-23-001303","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1920785/000101376223001303/ownership.xml","form_type":"4"}},{"id":1768013,"issuer":{"id":4785,"kind":"organization","name":"MoonLake Immunotherapeutics"},"owners":[{"id":78740,"kind":"person","name":"Sturge Simon","position":1,"cik":"0001920785","reported_name":"Sturge Simon","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Class A ordinary shares, par value $0.0001 per share","published_at":"2023-10-03T19:34:12.000Z","date":"2023-10-01","kind":"exercise","planned":false,"acquired":true,"shares":342980,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On October 1, 2023, the Reporting Person exchanged 10,196 common shares of MoonLake Immunotherapeutics AG (\"MoonLake AG\") for 342,980 Class A ordinary shares of the Issuer. In connection with the exchange, 342,980 Class C ordinary shares of the Issuer were automatically cancelled by the Issuer for no consideration."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The common shares of MoonLake AG may be exchanged at the holder's option into Class A ordinary shares at a rate of 1 common share of MoonLake AG for 33.638698 Class A ordinary shares, rounded to the nearest whole share. Upon any such exchange of a common share of MoonLake AG, the corresponding Class C ordinary share of the Issuer will be automatically cancelled."}],"balance_after":342980,"source":{"system":"sec-edgar","filing":"0001013762-23-001303","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1920785/000101376223001303/ownership.xml","form_type":"4"}},{"id":1859156,"issuer":{"id":4785,"kind":"organization","name":"MoonLake Immunotherapeutics"},"owners":[{"id":78740,"kind":"person","name":"Sturge Simon","position":1,"cik":"0001920785","reported_name":"Sturge Simon","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Buy","published_at":"2023-06-12T16:57:50.000Z","date":"2023-06-08","kind":"grant","planned":false,"acquired":true,"shares":11297,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option represents a right to purchase a total of 11,297 Class A Ordinary Shares of the Issuer, which will vest in full the earlier of (i) June 8, 2024 and (ii) the date of the Issuer's next annual general meeting of shareholders, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":11297,"derivative":{"exercise_price":29.18,"expiration_date":"2033-06-08","underlying":"Class A ordinary shares, par value $0.0001 per share","underlying_shares":11297},"source":{"system":"sec-edgar","filing":"0001213900-23-048209","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1920785/000121390023048209/ownership.xml","form_type":"4"}},{"id":2281015,"issuer":{"id":4785,"kind":"organization","name":"MoonLake Immunotherapeutics"},"owners":[{"id":78740,"kind":"person","name":"Sturge Simon","position":1,"cik":"0001920785","reported_name":"Sturge Simon","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Buy","published_at":"2022-05-05T17:51:12.000Z","date":"2022-04-06","kind":"grant","acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Mr. Sturge was granted 45,000 options on April 6, 2022 pursuant to the MoonLake Immunotherapeutics 2022 Equity Incentive Plan (the \"Plan\"), vesting one-third on each of April 6, 2023, April 6, 2024 and April 6, 2025, in each case, subject to the terms of the Plan. Each option represents the right to acquire one Class A ordinary share, par value $0.0001 per share, of the Issuer."}],"balance_after":45000,"derivative":{"exercise_price":12.25,"expiration_date":"2032-04-06","underlying":"Class A ordinary shares, par value $0.0001 per share","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0001213900-22-024307","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1920785/000121390022024307/ownership.xml","form_type":"4"}}]}